Skip to content
Screener

Medpace Holdings, Inc. MEDP Business Segments — Nonoperating Income (Expense)

Similar metrics at other companies

Analog Devices logo
ADIReportable Segment — Nonoperating Income (Expense)
-$54.85M-5.5%
Adobe logo
ADBEReportable Segment — Nonoperating Income (Expense)
$0+100%
Inhibrx Biosciences, Inc. logo
INBXReportable Segment — Nonoperating Income (Expense)
-$2.51M-513%
BridgeBio Pharma logo
BBIOReportable Segment — Nonoperating Income (Expense)
-$60.6M+7.1%
Momentus logo
MNTSReportable Segment — Nonoperating Income (Expense)
-$788K-6,162%
LPR
LPROReportable Segment — Nonoperating Income (Expense)
$163K+283%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense), net:
Miscellaneous (expense) income, net(147)(2,875)824(4,691)
Interest income, net4,9861,07810,1037,541
Total other income (expense), net4,839(1,797)10,9272,850
Income before income taxes151,663124,538299,254242,708
Income tax provision30,30134,27854,02237,853
Segment net income$121,362$90,260$245,232$204,855
Reconciliation of profit or loss

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s business segments — nonoperating income (expense)?
Medpace Holdings, Inc. (MEDP) reported business segments — nonoperating income (expense) of $4.84M in Q2 2026.
How has Medpace Holdings, Inc.'s business segments — nonoperating income (expense) changed year-over-year?
Medpace Holdings, Inc.'s business segments — nonoperating income (expense) increased by 369.3% year-over-year, from -$1.8M to $4.84M.
What is the long-term trend for Medpace Holdings, Inc.'s business segments — nonoperating income (expense)?
Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s business segments — nonoperating income (expense) has grown at a 21.4% compound annual growth rate (CAGR), from $4.16M to $7.44M.
What does business segments — nonoperating income (expense) mean?
Includes all financial activities outside of the core business operations, such as investment income, foreign exchange gains or losses, and other non-core financial items. This metric isolates the impact of external financial factors from the segment's operational performance.

Ask your AI about Medpace Holdings, Inc.'s business segments — nonoperating income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude